Not found

Blythe Gorman, MD

Associate Professor of Clinical Pathology and Genomic Medicine, Institute for Academic Medicine
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Gorman received her medical degree from the Louisiana State University School of Medicine in New Orleans in 2005, and completed her residency in anatomic and clinical pathology at The University of Texas Medical Branch (UTMB) in Galveston, Texas. Dr. Gorman then completed fellowships in surgical pathology and cytopathology at Houston Methodist Hospital where she joined the faculty as a staff pathologist in 2011. She earned numerous honors and awards during her education and training, including the UTMB Department of Pathology Teaching Award in 2007 and a first place medal for her podium presentation at the Texas Society of Pathologists John R. Rainey, MD Trainee Seminar in 2011.

Dr. Gorman is board-certified in anatomic and clinical pathology with subspecialty interest in cytopathology. Her research centers on outcomes and process improvement studies in cytopathology.

Education & Training

Residency, University of Texas Medical Branch
Clinical Fellowship, The Methodist Hospital
Publications

ROSE and endosonographer-driven telecytology: issues to consider
Gorman, BK & Schwartz, MR 2018, Journal of the American Society of Cytopathology, vol. 7, no. 2, pp. 86-91. DOI: 10.1016/j.jasc.2017.12.005

Negative Pap tests in women with high-grade cervical lesions on follow-up biopsies: Contributing factors and role of human papillomavirus genotyping
Goodman, S, Mody, RR, Coffey, D, Gorman, BK, Luna, E, Armylagos, D, Schwartz, MR, Mody, DR & Ge, Y 2018, Diagnostic cytopathology, vol. 46, no. 3, pp. 239-243. DOI: 10.1002/dc.23874

Cytologic Sampling Techniques
Gorman, B & Ramzy, I 2018, . in I Ramzy, D Mody & R Laucirica (eds), Clinical Cytopathology: Fundamental Principles and Practice. 3rd edn, McGraw Hill Education, pp. 29-36.

Programmed death ligand-1 (pd-l1) expression in either tumor cells or tumor-infiltrating immune cells correlates with solid and high-grade lung adenocarcinomas
Driver, BR, Miller, RA, Miller, T, Deavers, M, Gorman, B, Mody, D, Ge, Y, Barrios, R, Bernicker, E, Kim, M & Cagle, PT 2017, Archives of Pathology and Laboratory Medicine, vol. 141, no. 11, pp. 1529-1532. DOI: 10.5858/arpa.2017-0028-OA

Genetic and Environmental Models of Circadian Disruption Link SRC-2 Function to Hepatic Pathology
Fleet, T, Stashi, E, Zhu, B, Rajapakshe, K, Marcelo, KL, Kettner, NM, Gorman, BK, Coarfa, C, Fu, L, OMalley, BW & York, B 2016, Journal of Biological Rhythms, vol. 31, no. 5, pp. 443-460. DOI: 10.1177/0748730416657921

Determination of HER2/neu status: A pilot study comparing HER2/neu dual in situ hybridization DNA probe cocktail assay performed on cell blocks to immunohistochemisty and fluorescence in situ hybridization performed on histologic specimens
Hartman, AK, Gorman, BK, Chakraborty, S, Mody, DR & Schwartz, MR 2014, Archives of Pathology and Laboratory Medicine, vol. 138, no. 4, pp. 553-558. DOI: 10.5858/arpa.2013-0314-SA

Digital slide imaging in cervicovaginal cytology: A pilot study
Wright, AM, Smith, D, Dhurandhar, B, Fairley, T, Scheiber-Pacht, M, Chakraborty, S, Gorman, BK, Mody, D & Coffey, DM 2013, Archives of Pathology and Laboratory Medicine, vol. 137, no. 5, pp. 618-624. DOI: 10.5858/arpa.2012-0430-OA

Nasal gout presenting as nasal obstruction
Kwak, PE, Gorman, BK & Olson, KL 2013, JAMA Otolaryngology - Head and Neck Surgery, vol. 139, no. 4, pp. 411-413. DOI: 10.1001/jamaoto.2013.220

Comparison of breast carcinoma prognostic/predictive biomarkers on cell blocks obtained by various methods: Cellient, formalin and thrombin
Gorman, BK, Kosarac, O, Chakraborty, S, Schwartz, MR & Mody, DR 2012, Acta cytologica, vol. 56, no. 3, pp. 289-296. DOI: 10.1159/000337436

Malignant hepatic angiomyolipoma: Report of a case and review of literature
Nguyen, TT, Gorman, B, Shields, D & Goodman, Z 2008, American Journal of Surgical Pathology, vol. 32, no. 5, pp. 793-798. DOI: 10.1097/PAS.0b013e3181607349